These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15006373)

  • 41. Syntheses of 4-(indole-3-yl)quinazolines: a new class of epidermal growth factor receptor tyrosine kinase inhibitors.
    Lüth A; Löwe W
    Eur J Med Chem; 2008 Jul; 43(7):1478-88. PubMed ID: 17981366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovering novel 3-nitroquinolines as a new class of anticancer agents.
    Li HH; Huang H; Zhang XH; Luo XM; Lin LP; Jiang HL; Ding J; Chen KX; Liu H
    Acta Pharmacol Sin; 2008 Dec; 29(12):1529-38. PubMed ID: 19026174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Durutlic H; Chen JJ; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2005 Jun; 48(11):3891-902. PubMed ID: 15916442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elucidating inhibitory models of the inhibitors of epidermal growth factor receptor by docking and 3D-QSAR.
    Chen G; Luo X; Zhu W; Luo C; Liu H; Puah CM; Chen K; Jiang H
    Bioorg Med Chem; 2004 May; 12(9):2409-17. PubMed ID: 15080937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.
    Ballard P; Bradbury RH; Harris CS; Hennequin LF; Hickinson M; Johnson PD; Kettle JG; Klinowska T; Leach AG; Morgentin R; Pass M; Ogilvie DJ; Olivier A; Warin N; Williams EJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1633-7. PubMed ID: 16380259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Lin R; Johnson SG; Connolly PJ; Wetter SK; Binnun E; Hughes TV; Murray WV; Pandey NB; Moreno-Mazza SJ; Adams M; Fuentes-Pesquera AR; Middleton SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2333-7. PubMed ID: 19286381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
    Waterson AG; Petrov KG; Hornberger KR; Hubbard RD; Sammond DM; Smith SC; Dickson HD; Caferro TR; Hinkle KW; Stevens KL; Dickerson SH; Rusnak DW; Spehar GM; Wood ER; Griffin RJ; Uehling DE
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1332-6. PubMed ID: 19208477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening enzyme-inhibitory activity in several ascidian species from Orkney Islands using protein tyrosine kinase (PTK) bioassay-guided fractionation.
    Barenbrock JS; Köck M
    J Biotechnol; 2005 May; 117(3):225-32. PubMed ID: 15862352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.
    Yu Z; Boggon TJ; Kobayashi S; Jin C; Ma PC; Dowlati A; Kern JA; Tenen DG; Halmos B
    Cancer Res; 2007 Nov; 67(21):10417-27. PubMed ID: 17974985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase.
    Asano T; Yoshikawa T; Nakamura H; Uehara Y; Yamamoto Y
    Bioorg Med Chem Lett; 2004 May; 14(9):2299-302. PubMed ID: 15081028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
    Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
    Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
    Abouzid K; Shouman S
    Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epidermal growth factor receptor and human topoisomerases represent potential cellular targets of oligomeric procyanidins.
    Fridrich D; Kern M; Fritz J; Pahlke G; Köhler N; Winterhalter P; Marko D
    Mol Nutr Food Res; 2007 Feb; 51(2):192-200. PubMed ID: 17230588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.
    Ferrarini PL; Betti L; Cavallini T; Giannaccini G; Lucacchini A; Manera C; Martinelli A; Ortore G; Saccomanni G; Tuccinardi T
    J Med Chem; 2004 Jun; 47(12):3019-31. PubMed ID: 15163184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.
    Petrov KG; Zhang YM; Carter M; Cockerill GS; Dickerson S; Gauthier CA; Guo Y; Mook RA; Rusnak DW; Walker AL; Wood ER; Lackey KE
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4686-91. PubMed ID: 16777410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors.
    Gopalsamy A; Shi M; Boschelli DH; Williamson R; Olland A; Hu Y; Krishnamurthy G; Han X; Arndt K; Guo B
    J Med Chem; 2007 Nov; 50(23):5547-9. PubMed ID: 17941624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antibacterial evaluation of 1,2,3,4-tetrahydro-4-oxo-1,8-naphthyridine-3-carboxylic acid esters, carbonitriles, and carboxamides.
    Santilli AA; Scotese AC; Yurchenco JA
    J Med Chem; 1975 Oct; 18(10):1038-41. PubMed ID: 1099201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-Anilino-3-cyanobenzo[g]quinolines as kinase inhibitors.
    Zhang N; Wu B; Wissner A; Powell DW; Rabindran SK; Kohler C; Boschelli F
    Bioorg Med Chem Lett; 2002 Feb; 12(3):423-5. PubMed ID: 11814812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unexpected behavior of enaminones: interesting new routes to 1,6-naphthyridines, 2-oxopyrrolidines and pyrano[4,3,2-de][1,6]naphthyridines.
    Moustafa MS; Al-Mousawi SM; Hilmy NM; Ibrahim YA; Liermann JC; Meier H; Elnagdi MH
    Molecules; 2012 Dec; 18(1):276-86. PubMed ID: 23271466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naphthyridines part 4: unprecedented synthesis of polyfunctionally substituted benzo[c][2,7]naphthyridines and benzo[c]pyrimido[4,5,6-ij][2,7]naphthyridines with structural analogy to pyrido[4,3,2-mn]acridines present in the marine tetracyclic pyridoacridine alkaloids.
    Mekheimer RA; Al-Sheikh MA; Medrasi HY; Bahatheg GA
    Mol Divers; 2018 Feb; 22(1):159-171. PubMed ID: 29164475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.